| 1 | Separation of human urinary erythropoietin from glycoproteins of similar size using concanavalin A Sepharose (Sieber F, Iscove NN, Winterhalter KH) Experientia 1973;29(6):758 1 Citation |
| 1 | Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. (Iscove NN, Sieber F, Winterhalter KH) J Cell Physiol 1974 Apr;83(2):309-20 670 Citations |
| 1 | Chromatography of human urinary erythropoietin and granulocyte colony-stimulating factor on insolubilized phytohaemagglutinin. (Sieber F) Biochim Biophys Acta 1977 Jan 24;496(1):146-54 3 Citations |
| 1 | Erythropoietin treatment in patients with myelodysplastic syndrome and anemia. (Kurzrock R, Talpaz M, Estey E, O'Brien S, Estrov Z, Gutterman JU) Leukemia 1991 Nov;5(11):985-90 44 Citations |
| 1 | Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia. (Kurzrock R, Talpaz M, Gutterman JU) Am J Med 1992 Jul;93(1):41-8 29 Citations |
| 1 | A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. (Goodnough LT, Price TH, Friedman KD, Johnston M, Ciavarella D, Khan N, Sacher R, Vogler WR, Wissel M, Abels RI) Transfusion 1994 Jan;34(1):66-71 117 Citations |
| 1 | Erythropoietin response to anaemia is not altered by surgery or recombinant human erythropoietin therapy. (Goodnough LT, Price TH, Parvin CA, Friedman KD, Vogler WR, Khan N, Sacher R, Johnston M, Wissel M, Ciavarella D) Br J Haematol 1994 Aug;87(4):695-9 35 Citations |
| 1 | Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. (Quelle FW, Wang D, Nosaka T, Thierfelder WE, Stravopodis D, Weinstein Y, Ihle JN) Mol Cell Biol 1996 Apr;16(4):1622-31 243 Citations |
| 1 | Safety and efficacy of erythropoietin in children with chronic renal failure. (Brandt JR, Avner ED, Hickman RO, Watkins SL) Pediatr Nephrol 1999 Feb;13(2):143-7 52 Citations |
| 1 | Intravenous iron dextran and erythropoietin use in pediatric hemodialysis patients. (Greenbaum LA, Pan CG, Caley C, Nelson T, Sheth KJ) Pediatr Nephrol 2000 Sep;14(10-11):908-11 19 Citations |
| 1 | Erythropoietin: a paradigm for the development of practice guidelines. (Rizzo JD, Seidenfeld J, Piper M, Aronson N, Lichtin A, Littlewood TJ) Hematology Am Soc Hematol Educ Program 2001:10-30 35 Citations |
| 2 | Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels. (Shi Y, Rafiee P, Su J, Pritchard KA Jr, Tweddell JS, Baker JE) Basic Res Cardiol 2004 May;99(3):173-82 80 Citations |
| 1 | Subnormal rise of erythropoietin in patients receiving interferon and ribavirin combination therapy for hepatitis C. (Trivedi HS, Trivedi M) J Clin Gastroenterol 2004 Aug;38(7):595-8 14 Citations |
| 2 | Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. (Rafiee P, Shi Y, Su J, Pritchard KA Jr, Tweddell JS, Baker JE) Basic Res Cardiol 2005 May;100(3):187-97 98 Citations |
| 1 | Erythropoietin mimics ischemic preconditioning. (Baker JE) Vascul Pharmacol 2005;42(5-6):233-41 66 Citations |
| 1 | Increased erythropoietin elimination in fetal sheep following chronic phlebotomy. (Freise KJ, Widness JA, Segar JL, Schmidt RL, Veng-Pedersen P) Pharm Res 2007 Sep;24(9):1653-9 7 Citations |
| 1 | Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series. (Chawla B, Iqbal FM, Chawla MS) Compr Ther 2009;35(3-4):199-203 5 Citations |
| 1 | Editorial Comment to Renoprotective effect of erythropoietin in ischemia/reperfusion injury: possible roles of the Akt/endothelial nitric oxide synthase-dependent pathway. (Regner KR) Int J Urol 2012 Mar;19(3):256 |
| 1 | Erythropoietin protects cardiomyocytes from cell death during hypoxia/reperfusion injury through activation of survival signaling pathways. (Parvin A, Pranap R, Shalini U, Devendran A, Baker JE, Dhanasekaran A) PLoS One 2014;9(9):e107453 28 Citations |
| 1 | Erythropoietin Stimulates Tumor Growth via EphB4. (Pradeep S, Huang J, Mora EM, Nick AM, Cho MS, Wu SY, Noh K, Pecot CV, Rupaimoole R, Stein MA, Brock S, Wen Y, Xiong C, Gharpure K, Hansen JM, Nagaraja AS, Previs RA, Vivas-Mejia P, Han HD, Hu W, Mangala LS, Zand B, Stagg LJ, Ladbury JE, Ozpolat B, Alpay SN, Nishimura M, Stone RL, Matsuo K, Armaiz-Peña GN, Dalton HJ, Danes C, Goodman B, Rodriguez-Aguayo C, Kruger C, Schneider A, Haghpeykar S, Jaladurgam P, Hung MC, Coleman RL, Liu J, Li C, Urbauer D, Lopez-Berestein G, Jackson DB, Sood AK) Cancer Cell 2015 Nov 09;28(5):610-622 75 Citations |
| 2 | Recombinant erythropoietin mitigates reperfusion injury in neonatal rat cardiomyocytes by novel multiple signalling pathways (Allaudeen AP, Koka P, Pant T, Chandramohan Y, Sivanesan S, Baker JE, Dhanasekaran A) International Journal of Pharmacy and Pharmaceutical Sciences 2016;8(12):34-40 1 Citation |
| 1 | ERYTHROPOIETIN (Spivak JL, Sieber F) Hormones in Normal and Abnormal Human Tissues: Volume 3 1 January 2019;3:63-96 1 Citation |
© 2025 Clinical & Translational Science Institute